The -1 programmed ribosomal frameshifting (-1 PRF) in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is crucial for keeping the balance between pp1a and pp1ab polyproteins. To date, the host factors influencing this process remain poorly understood. Using RNA pull-down assays combined with mass spectrometry screening, we discovered five host proteins interacting with -1 PRF RNA, including Stem Loop Binding Protein (SLBP). Our findings revealed that SLBP overexpression enhanced frameshifting and promoted viral replication. Moreover, the interaction between SLBP and -1 PRF RNA was predicted using the PrismNet deep learning tool, which calculated a high binding probability of 0.922. Using Electrophoretic Mobility Shift Assays (EMSAs) and RNA pull down assays, our findings demonstrated SLBP's direct binding to the SARS-CoV-2 genome, with preferential affinity for the stem loop 3 region of the -1 PRF RNA. Using smFISH assays, we further confirmed their physical colocalization. The role of SLBP in promoting frameshifting was verified using an in vitro translation system. Further investigation showed that SLBP deletions reshaped the host factor pattern around -1 PRF RNA, diminishing interactions with FUBP3 and RPS3A while enhancing RPL10A binding. Together, our findings identify SLBP as a host protein that promotes SARS-CoV-2 frameshifting, highlighting its potential as a druggable target for COVID-19.
Stem loop binding protein promotes SARS-CoV-2 replication via -1 programmed ribosomal frameshifting.
茎环结合蛋白通过-1程序性核糖体移码促进SARS-CoV-2复制
阅读:9
作者:Chen Tanxiu, Zhu Ruimin, Du Tingfu, Yang Hao, Zhang Xintian, Wang Zhixing, Zhang Yong, Quan Wenqi, Yin Bin, Liu Yunpeng, Lu Shuaiyao, Peng Xiaozhong
| 期刊: | Signal Transduction and Targeted Therapy | 影响因子: | 52.700 |
| 时间: | 2025 | 起止号: | 2025 Jun 13; 10(1):192 |
| doi: | 10.1038/s41392-025-02277-w | 研究方向: | 炎症/感染 |
| 疾病类型: | 新冠 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
